FXR activation mitigates renal fibrosis through various mechanisms, including suppression of pro‐inflammatory cytokines, reduction of oxidative stress, and inhibition of EMT in renal tubular cells [24, 43, 44]. This evidence concerns the gene NR1H4 and renal fibrosis.